Open AccessEquivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data update
Author(s) -
Jun Lü,
Tianqing Chu,
Hongyu Liu,
Maoliang Hu,
YuQing Lou,
Yanwei Zhang,
Zhiqiang Gao,
Wei Zhang,
Xueyan Zhang,
Huimin Wang,
Hua Zhong,
Baohui Han
Publication year - 2022
Publication title -
chinese journal of cancer research/chinese journal of cancer research
Language(s) - English
Resource type - Journals
eISSN - 1993-0631
pISSN - 1000-9604
DOI - 10.21147/j.issn.1000-9604.2022.01.03
Subject(s) - bevacizumab , medicine , confidence interval , clinical endpoint , lung cancer , log rank test , randomized controlled trial , oncology , progression free survival , gastroenterology , survival analysis , overall survival , chemotherapy